Medical Benefit Specialty Management: The Next Frontier in Specialty Cost Management

Specialty drug spend has always been a focus for payers, but a growing share of that spend no longer flows through the pharmacy benefit at all. High-cost, provider-administered, and infused therapies increasingly fall under the medical benefit, where visibility, coordination, and cost management have traditionally lagged behind pharmacy-side controls. As this shift continues, payers managing specialty spend through pharmacy channels alone are missing a meaningful and growing part of the picture.

Medical Benefit Specialty Management is emerging as a distinct and necessary discipline, one that looks at the therapy, the site of care, fulfillment, the clinical pathway, and the financial strategy together rather than in isolation. Approached this way, medical benefit specialty spend becomes an opportunity for greater visibility and control, and for optimizing total cost of care, rather than simply another category of claims to contain.

What Is Medical Benefit Specialty Management?

Medical benefit specialty management is the practice of managing high-cost, provider-administered, and infused specialty therapies billed under the medical benefit, rather than the pharmacy benefit, by connecting the therapy, site of care, fulfillment, clinical pathway, and financial strategy through one coordinated approach. It exists because these therapies have historically been managed with less visibility and coordination than pharmacy benefit specialty drugs, even though the cost and clinical stakes are often just as high.

The Visibility Gap in Medical Benefit Specialty Spend

Provider-administered and infused therapies can represent some of the highest costs a payer manages, yet they are often the least visible. Traditional pharmacy management tools are built around retail and specialty pharmacy claims, not around what happens when a therapy is billed through the medical benefit. That leaves gaps: incomplete data on where a therapy was administered, how its cost varies across different sites of care, and how it fits into the patient’s broader treatment journey.

This is not simply a data problem. It is a strategic one. Without a clear view of medical benefit specialty spend, payers are effectively managing a significant and growing category of cost with partial information, making it difficult to identify where the greatest opportunities for improvement lie.

Site-of-Care Optimization: An Opportunity, Not a Mandate

One of the more immediate opportunities within medical benefit specialty management is site-of-care optimization. Many infused and provider-administered therapies can be delivered in more than one setting, and the cost difference between a hospital outpatient department, an ambulatory infusion center, and home-based care can be substantial.

That said, site-of-care optimization is not about moving every therapy to the lowest-cost setting available. Clinical appropriateness and patient access have to come first. Some patients and therapies require the clinical infrastructure of a hospital setting, and the goal is not a blanket policy but a case-by-case evaluation, supported by clinical expertise and coordination, of where a therapy can be delivered safely and effectively.

Connecting Medical and Pharmacy Benefits

Medical benefit specialty management works best when it is not treated as a separate initiative from pharmacy benefit management. The two are increasingly intertwined, and many of the more meaningful opportunities sit at the intersection: a therapy that could be filled through a specialty pharmacy rather than billed under the medical benefit, a rebate opportunity that only becomes visible when medical and pharmacy claims are viewed together, or a care-coordination gap that only shows up when both benefits are considered as one patient journey rather than two separate ones.

The strategic shift here is to connect medical and pharmacy benefits rather than manage them in parallel. That connection is what turns fragmented data points into a coherent view of total cost of care, and it is the difference between reacting to individual claims and proactively managing a category of spend with real visibility and control.

A Multi-Pronged Strategy for Complex Specialty Spend

Because medical benefit specialty spend touches so many parts of the care and cost equation, no single lever is likely to move it meaningfully on its own. An integrated, multi-pronged approach, one that brings together site-of-care optimization, specialty pharmacy access, drug-level pricing, rebate capture, care coordination, and analytics, gives payers more ways to identify and act on opportunities than any single strategy could offer alone.

This is also where specialty fulfillment and care coordination become more than operational details. When a therapy moves smoothly from clinical decision to appropriate site of care to fulfillment, with the financial and clinical sides of that journey connected rather than managed in separate silos, payers gain both better coordination and a clearer picture of what is actually driving cost.

The Value Is Broader Than the Claim

It can be tempting to frame medical benefit specialty management purely as a cost-containment exercise, but that framing undersells what an integrated approach actually offers. The real value is in managing specialty therapies more deliberately: preserving clinical appropriateness and patient access, improving coordination across the care journey, and building the visibility and control needed to make informed decisions, rather than simply capturing savings on individual claims one at a time.

Payers who approach this well are not looking for a single fix. They are building a more connected way of seeing and managing a category of spend that has outgrown the tools most organizations originally built for it.

How AscellaOne Supports Medical Benefit Specialty Management

This is the strategic gap AscellaHealth’s AscellaOne platform is built to help payers close. By connecting medical and pharmacy benefit data, specialty pharmacy access, and clinical coordination, AscellaOne helps payers identify, manage, and act on opportunities within complex medical specialty spend, from site-of-care evaluation to rebate capture to care coordination. That includes access to more than 100 rebate-eligible specialty drugs, a network of more than 25 accredited pharmacy partners, and 100% access to Limited Distribution Drugs, capabilities that exist to support a broader strategy rather than serve as a substitute for one. Learn more about AscellaOne here: https://ascellahealth.com/ascellaone

As specialty therapies continue to move under the medical benefit, payers best positioned to manage that shift will be those who stop treating medical and pharmacy benefit spend as separate problems and start managing them as one connected system, with visibility and control at the center.

Frequently Asked Questions

What is medical benefit specialty management?

Medical benefit specialty management brings the therapy, site of care, fulfillment, clinical pathway, and financial strategy together into one coordinated approach, rather than managing each piece separately across the medical benefit.

Why does site-of-care optimization matter for specialty drugs?

Site-of-care optimization matters because the cost of delivering an infused or provider-administered therapy can vary significantly between a hospital outpatient department, an ambulatory infusion center, and home-based care. When clinically appropriate, moving a therapy to a lower-cost setting can help reduce total cost of care without compromising patient outcomes.

Does site-of-care optimization mean moving every therapy to a lower-cost setting?

Site-of-care optimization should not be applied as a blanket policy across all therapies or patients. Each case should be evaluated individually, based on clinical appropriateness and patient access.

How does connecting medical and pharmacy benefits help manage specialty drug costs?

Connecting medical and pharmacy benefits gives payers a single view of utilization, fulfillment, pricing, and rebate opportunities that are often missed when the two benefits are managed separately, helping identify opportunities to optimize specialty spend more effectively.

What does an integrated approach to medical benefit specialty management include?

An integrated, multi-pronged approach typically combines site-of-care optimization, specialty pharmacy access, drug-level pricing, rebate capture, care coordination, and analytics, since no single strategy can address the full complexity of medical benefit specialty spend on its own.